Worth Watching Stocks Under Consideration: Monsanto Company (NYSE:MON), Telefonica S.A. (ADR)(NYSE:TEF), Immunomedics, Inc. (NASDAQ:IMMU)

On Thursday, Shares of Monsanto Company (NYSE:MON), subtract -1.02% and closed at $97.93 in the last trading session. The last trading range of the stock ranges between $97.75 and $99.40. Monsanto Company (MON) declared recently that the EPA has approved XtendiMaxTM herbicide with VaporGripTM Technology, a low-volatility dicamba herbicide, for in-crop use with Roundup Ready 2 Xtend® soybeans and Bollgard II® XtendFlex® cotton. This noteworthymilestone will provide farmers the opportunity to utilize dicamba in the Roundup Ready® Xtend Crop System in 2017.

With XtendiMax with VaporGrip Technology approved for in-crop use by EPA, farmers can now look forward to another tool for use within the Roundup Ready Xtend Crop System in the United States in 2017, pending state approvals. Monsanto is in a strong position to supply dicamba demand to support the Roundup Ready Xtend Crop System in soybeans and cotton. Monsanto projects over 15 million Roundup Ready 2 Xtend soybean acres and over 3 million acres of Bollgard II XtendFlex cotton in 2017.

Telefonica S.A. (ADR)(NYSE:TEF), subtract -3.63% and closed at $9.29 in the last trading session. The last trading range of the stock ranges between $9.23 and $9.43. The company’s Market capitalization is $45.09 Billion with the total Outstanding Shares of 4.69 billion. Telefónica, S.A. provides mobile and fixed communication services mainly in the European Union and Latin America. The company’s mobile and related services and products comprise mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone services; local, domestic, and international long-distance and fixed-to-mobile communications; corporate communications; supplementary and business oriented value-added; video telephony; intelligent network; and telephony information services. The company also leases and sells handset equipment, in addition to provides Internet and broadband multimedia services comprising Internet service provider; portal and network; retail and wholesale broadband access; narrowband switched access to Internet; high-speed Internet services through fiber to the home; and VoIP services. In addition, it offers data and business-solutions services that include leased lines; virtual private network; fiber optics; hosting and application; outsourcing and consultancy; desktop; and system integration and professional services.

Immunomedics, Inc. (NASDAQ:IMMU), jumped 0.83% and closed at $2.42 in the last trading session. The last trading range of the stock ranges between $2.35 and $2.48. During the 52-week trading session the minimum price at which share price traded, registered at $1.61 and reached to max level of $5.44. Immunomedics, Inc. (IMMU) recently declared that the Company was honored by the Research & Development Council of New Jersey with their coveted Edison Patent Award, in recognition of the Company’s noteworthyachievements in the biotechnology category for its novel immuno-oncology program.

“We are delighted to receive this prestigious award for the fourth time,” commented Cynthia L. Sullivan, President and Chief Executive Officer of Immunomedics. “We are excited to be recognized by our peers for creating our own immuno-oncology agents for solid cancer therapy using our proprietary Dock-and-Lock® protein conjugation platform technology,” Ms. Sullivan further remarked. “One of these agents will be the subject of an forthcoming presentation at the 2016 San Antonio Breast Cancer Symposium on redirected T-cell therapy of triple-negative breast cancer, which can be improved by combining it with our own proprietary immune checkpoint inhibitor,” she concluded.

Leave a Reply

Your email address will not be published. Required fields are marked *